您的位置: 首页 > 2022年11月 第52卷 第6期 > 文字全文
2023年7月 第38卷 第7期11
目录

闽西南地区炎症性肠病诊治特征的研究

Diagnostic and treatment features of regional inflammatory bowel disease

来源期刊: 广州医药 | 89-95 发布时间:2022-11-30 收稿时间:2025/11/13 18:15:14 阅读量:121
作者:
关键词:
克罗恩病溃疡性结肠炎炎症性肠病
Crohn's diseaseulcerative colitisinflammatory bowel disease
DOI:
10.3969/j.issn.1000-8535.2022.06.019
收稿时间:
2022-05-25 
修订日期:
 
接收日期:
 
引用总数:
2  
目的 分析闽西南地区在院炎症性肠病患者流行病学资料,从而加强对炎症性肠病的认识。方法 回顾性研究炎症性肠病患者临床特点及用药情况。结果 纳入317例炎症性肠病,克罗恩病占212例,男女之比 2.07:1,溃疡性结肠炎占105例,男女比例1.84:1。克罗恩病患者确诊平均年龄29岁,以患A2型为主,溃疡性结肠炎者确诊平均年龄44岁。女性B2型比例明显高于男性。溃疡性结肠炎患者的病变部位主要为E3型(44.8%)。结论 炎症性肠病患者临床表现多样。克罗恩病确诊年龄主要是A2型, L3型是主要病变部位分型,B2型是疾病行为主要分型。E3型是溃疡性结肠炎患者的主要病变部位。克罗恩病多以免疫抑制剂和生物制剂治疗,糖皮质激素和5-ASA类制剂是轻中度的UC患者主要治疗措施。生物制剂、糖皮质激素治疗多用于重度UC患者。
Objective To analyze the epidemiological data of inflammatory bowel disease (IBD)patients in southwest Fujian Province, so as to improve the understanding of IBD. Methods To retrospectively study the clinical characteristics and medication of inflammatory bowel disease patients. Results A total of 317 IBD patients were included.Crohn's disease accounted for 212 cases, with a male-to-female ratio of 2.07:1, and ulcerative colitis accounted for 105 cases, with a male-to-female ratio of 1.84:1.Patients with Crohn's disease were diagnosed at an average age of 29, mainly with type A2, while patients with ulcerative colitis were diagnosed at an average age of 44. The proportion of female with type B2 was significantly higher than that of male.The lesions of ulcerative colitis patients were mainly type E3 (44.8%).Conclusions Patients with IBD had diverse clinical manifestations.The age of diagnosis of Crohn's disease was mainly type A2, type L3 was the main lesion, type B2 was the main disease classification.Crohn's disease was mainly treated with immunosuppressive and biological therapy. Glucocorticoids and 5-ASA were the main treatment for patients with mild-to-moderate ulcerative colitis. Biological agents and glucocorticoid therapy were mostly used in severe patients.
1、 PARK S J, KIM W H, CHEON J H. Clinical characteristics and treatment of inflammatory bowel disease:a comparison of Eastern and Western perspectives[J]. World J Gastroenterol, 2014,20(33): 11525-11537. PARK S J, KIM W H, CHEON J H. Clinical characteristics and treatment of inflammatory bowel disease:a comparison of Eastern and Western perspectives[J]. World J Gastroenterol, 2014,20(33): 11525-11537.
2、 PRIDEAUX L, KAMM M A, de CRUZ P, et al. Comparison of clinical characteristics and management of inflammatory bowel disease in Hong Kong versus Melbourne[J]. JGastroenterol Hepatol, 2012, 27(5): 919-927. PRIDEAUX L, KAMM M A, de CRUZ P, et al. Comparison of clinical characteristics and management of inflammatory bowel disease in Hong Kong versus Melbourne[J]. JGastroenterol Hepatol, 2012, 27(5): 919-927.
3、 SIMIAN D, FLUXá D, FLORES L,et al. Inflammatory bowel disease: A descriptive study of 716 local Chilean patients[J]. World J Gastroenterol, 2016, 22(22): 5267-5275. SIMIAN D, FLUXá D, FLORES L,et al. Inflammatory bowel disease: A descriptive study of 716 local Chilean patients[J]. World J Gastroenterol, 2016, 22(22): 5267-5275.
4、 PEYRIN-BIROULET L, BOUHNIK Y, ROBLIN X, et al. French national consensus clinical guidelines for the management of ulcerative colitis[J]. Dig Liver Dis, 2016, 48(7): 726-733. PEYRIN-BIROULET L, BOUHNIK Y, ROBLIN X, et al. French national consensus clinical guidelines for the management of ulcerative colitis[J]. Dig Liver Dis, 2016, 48(7): 726-733.
5、 CHEN L, YANG J, FANG L, et al. The Degree of Ulcerative Colitis Burden of Luminal Inflammation score is superior to predicting medium-to long-term prognosis in patients with active ulcerative colitis[J]. Therap Adv Gastroenterol, 2020(13): 1756284820981210. CHEN L, YANG J, FANG L, et al. The Degree of Ulcerative Colitis Burden of Luminal Inflammation score is superior to predicting medium-to long-term prognosis in patients with active ulcerative colitis[J]. Therap Adv Gastroenterol, 2020(13): 1756284820981210.
6、 ROWAN C R, CULLEN G, MULCAHY H E,et al. DUBLIN [Degree of Ulcerative Colitis Burden of Luminal Inflammation] score, a simple method to quantify inflammatory burden in ulcerative colitis[J]. J Crohns Colitis, 2019, 13(11): 1365-1371. ROWAN C R, CULLEN G, MULCAHY H E,et al. DUBLIN [Degree of Ulcerative Colitis Burden of Luminal Inflammation] score, a simple method to quantify inflammatory burden in ulcerative colitis[J]. J Crohns Colitis, 2019, 13(11): 1365-1371.
7、 INGLE S B, LOFTUS E V Jr. The natural history of perianal Crohn's disease[J]. Dig Liver Dis, 2007, 39(10): 963-969. INGLE S B, LOFTUS E V Jr. The natural history of perianal Crohn's disease[J]. Dig Liver Dis, 2007, 39(10): 963-969.
8、 GUPTA N, BOSTROM A G, KIRSCHNER B S,et al. Gender differences in presentation and course of disease in pediatric patients with Crohn disease[J]. Pediatrics, 2007, 120(6): 1418-1425. GUPTA N, BOSTROM A G, KIRSCHNER B S,et al. Gender differences in presentation and course of disease in pediatric patients with Crohn disease[J]. Pediatrics, 2007, 120(6): 1418-1425.
9、 杨荣萍, 高翔,何瑶等.中国南方地区克罗恩病蒙特利尔分型特征分析[J]. 胃肠病学和肝病学杂志, 2014,23(1): 70-74. 杨荣萍, 高翔,何瑶等.中国南方地区克罗恩病蒙特利尔分型特征分析[J]. 胃肠病学和肝病学杂志, 2014,23(1): 70-74.
10、 ZHAO J, NG S C, LEI Y,et al. First prospective, population-based inflammatory bowel disease incidence study in mainland of China: the emergence of “western” disease[J]. Inflamm Bowel Dis, 2013,19(9):1839-1845. ZHAO J, NG S C, LEI Y,et al. First prospective, population-based inflammatory bowel disease incidence study in mainland of China: the emergence of “western” disease[J]. Inflamm Bowel Dis, 2013,19(9):1839-1845.
11、 FREEMAN H J. Application of the Montreal classification for Crohn's disease to a single clinician database of 1015 patients[J]. Can J Gastroenterol, 2007, 21(6): 363-366. FREEMAN H J. Application of the Montreal classification for Crohn's disease to a single clinician database of 1015 patients[J]. Can J Gastroenterol, 2007, 21(6): 363-366.
12、 LI X, SONG P, LI J, et al. The disease burden and clinical characteristics of inflammatory bowel disease in the Chinese population: A systematic review and Meta-analysis[J]. Int J Environ Res Public Health, 2017, 14(3):238. LI X, SONG P, LI J, et al. The disease burden and clinical characteristics of inflammatory bowel disease in the Chinese population: A systematic review and Meta-analysis[J]. Int J Environ Res Public Health, 2017, 14(3):238.
13、 SOON I S, MOLODECKY N A, RABI D M,et al. The relationship between urban environment and the inflammatory bowel diseases: A systematic review and meta-analysis[J]. BMC Gastroenterol, 2012(12): 51. SOON I S, MOLODECKY N A, RABI D M,et al. The relationship between urban environment and the inflammatory bowel diseases: A systematic review and meta-analysis[J]. BMC Gastroenterol, 2012(12): 51.
14、 NG S C, KAPLAN G G, TANG W, et al. Population density and risk of inflammatory bowel disease: A prospective population-based study in 13 countries or regions in Asia-Pacific[J]. Am J Gastroenterol, 2019,114(1): 107-115. NG S C, KAPLAN G G, TANG W, et al. Population density and risk of inflammatory bowel disease: A prospective population-based study in 13 countries or regions in Asia-Pacific[J]. Am J Gastroenterol, 2019,114(1): 107-115.
15、 吴开春,梁洁,钱家鸣,等. 炎症性肠病诊断与治疗的共识意见(2018年,北京)[J]. 中华消化杂志, 2018,38(5): 292-311. 吴开春,梁洁,钱家鸣,等. 炎症性肠病诊断与治疗的共识意见(2018年,北京)[J]. 中华消化杂志, 2018,38(5): 292-311.
16、 ANANTHAKRISHNAN A N. Epidemiology and risk factors for IBD[J]. Nat Rev Gastroenterol Hepatol, 2015, 12(4): 205-217. ANANTHAKRISHNAN A N. Epidemiology and risk factors for IBD[J]. Nat Rev Gastroenterol Hepatol, 2015, 12(4): 205-217.
1、周一多.清热燥湿类经典名方内服治疗溃疡性结肠炎的网状meta分析[D].江西中医药大学,2023.DOI:10.27180/d.cnki.gjxzc.2023.000514. 周一多.清热燥湿类经典名方内服治疗溃疡性结肠炎的网状meta分析[D].江西中医药大学,2023.DOI:10.27180/d.cnki.gjxzc.2023.000514.
2、陆文鹏.克罗恩病中医分型及与氧化应激相关机制探索[D].扬州大学,2023.DOI:10.27441/d.cnki.gyzdu.2023.002946. 陆文鹏.克罗恩病中医分型及与氧化应激相关机制探索[D].扬州大学,2023.DOI:10.27441/d.cnki.gyzdu.2023.002946.
上一篇
下一篇
出版者信息








《广州医药》公众号
目录